Jan Mattsson Albireo Pharma, Inc. (ALBO) insider trading activity

Jan Mattsson is Chief Scientific Officer of ALBIREO PHARMA, INC.. Currently has a direct ownership of 0 shares of ALBO, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 35,524 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Jan Mattsson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 02 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	35,524 Reduced 100.0%	0 Common Stock
Jan 23 2023	SELL Open market or private sale	$8,628 $43.8 p/Share	197 Reduced 0.36%	54,474 Common Stock
Jan 19 2023	SELL Open market or private sale	$135,254 $43.8 p/Share	3,088 Reduced 5.35%	54,671 Common Stock
Jan 19 2023	BUY Grant, award, or other acquisition	-	55,000 Added 33.44%	109,474 Common Stock
Oct 24 2022	SELL Open market or private sale	$3,955 $19.58 p/Share	202 Reduced 0.35%	57,759 Common Stock
Jul 22 2022	SELL Open market or private sale	$5,059 $24.68 p/Share	205 Reduced 0.35%	57,961 Common Stock
Apr 22 2022	SELL Open market or private sale	$6,584 $32.92 p/Share	200 Reduced 0.34%	58,166 Common Stock

Jan 24 2022	SELL Open market or private sale	$20,103 $24.88 p/Share	808 Reduced 1.37%	58,366 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	21,600 Added 26.74%	59,174 Common Stock
Mar 03 2021	SELL Open market or private sale	$14,480 $36.2 p/Share	400 Reduced 1.05%	37,574 Common Stock
Mar 02 2021	SELL Open market or private sale	$577,024 $36.59 p/Share	15,770 Reduced 29.34%	37,974 Common Stock
Mar 01 2021	SELL Open market or private sale	$572,985 $37.45 p/Share	15,300 Reduced 22.16%	53,744 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$39,330 $1.0 p/Share	39,330 Added 36.29%	69,044 Common Stock
Jan 21 2021	BUY Grant, award, or other acquisition	-	5,500 Added 15.62%	29,714 Common Stock

Jan Mattsson

Chief Scientific Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALBO shares.

Notify only if

Value

Insider Trading

Get notified when an Albireo Pharma, Inc. insider buys or sells ALBO shares.

Notify only if

Operation

Value

Type

News

Receive news related to ALBIREO PHARMA, INC.

Track Activities on ALBO

Account